Among clinical populations, a single dose of intranasal oxytocin has been reported to improve the interpretation of complex emotions among people with schizophrenia and depression, comprising disorders characterised by difficulties in the interpretation of emotions 16, 20. Here, OXT is linked to major depressive disorder.